(Q47635686)

English

Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators

scientific article published on 13 June 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

1 reference

based on heuristic

2

object named as

Johan Vijgen

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

author name string

Task force members

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Gianluca Botto

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

John Camm

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Carl-Johan Hoijer

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Werner Jung

6

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Jean-Yves Le Heuzey

7

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Andrzej Lubinski

8

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Tone M Norekvål

9

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Maurizio Santomauro

10

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Martin Schalij

11

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Jean-Paul Schmid

12

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Panos Vardas

13

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

publication date

13 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

11

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

8

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

1097-1107

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Legal and ethical aspects of driving and working in patients with an implantable cardioverter defibrillator

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Driving and implantable cardioverter-defibrillators a clearer view.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Driving and arrhythmias: implications of new data

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Causes of impaired consciousness while driving a motorized vehicle

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Incidence and implications of natural deaths of road users

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

What are the current guidelines on the use of implantable defibrillators in transportation safety critical work?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of P

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Addendum to "Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations: a medical/scientific statement from the American Heart Association and the North American

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Patients with implantable cardioverter-defibrillators and their conceptions of the life situation: a qualitative analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Motor vehicle accidents in patients with an implantable cardioverter-defibrillator.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Medical restrictions to driving: the awareness of patients and doctors

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Modification of patient driving behavior after implantation of a cardioverter defibrillator.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Should patients with implantable cardioverter-defibrillators be allowed to drive? Observations in 291 patients from a single center over an 11-year period

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Resumption of driving after life-threatening ventricular tachyarrhythmia

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Syncope, driving recommendations, and clinical reality: survey of patients

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Sudden death behind the wheel from natural disease in drivers of four-wheeled motorized vehicles

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: implications for antiarrhythmic therapy and driving restrictions. CARE Group

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable cardioverter-defibrillator

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Syncope following cardioverter defibrillator implantation in patients with spontaneous syncopal monomorphic ventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia. Implications for driving restrictions

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Low incidence of lead related complications associated with nonthoracotomy implantable cardioverter defibrillator systems.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Timing of delayed perforation with the St. Jude Riata lead: a single-center experience and a review of the literature

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Performance of the St. Jude Medical Riata leads

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HR

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Prognostic importance of defibrillator shocks in patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) tria

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Effects of antiarrhythmic drugs on inappropriate shocks in patients with implantable cardioverter defibrillators

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Effect of exercise training in patients with an implantable cardioverter defibrillator.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Benefits of cardiac rehabilitation in patients with implantable cardioverter-defibrillators: a patient survey

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Identifiers

10.1093/EUROPACE/EUP112

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47635686&oldid=2163844469"